Kir6.2 Polymorphisms Sensitize β-Cell ATP-Sensitive Potassium Channels to Activation by Acyl CoAs
A Possible Cellular Mechanism for Increased Susceptibility to Type 2 Diabetes?
- 1Department of Pharmacology, University of Alberta, Edmonton, Alberta, Canada
- 2Department of Mathematics and Statistics, University of Alberta, Edmonton, Alberta, Canada
- Address correspondence and reprint requests to Peter E. Light, University of Alberta, Department of Pharmacology, 9-58 Medical Sciences, Edmonton, Alberta T6G 2H7, Canada. E-mail: peter.light{at}ualberta.ca
Abstract
The commonly occurring E23K and I337V Kir6.2 polymorphisms in the ATP-sensitive potassium (KATP) channel are more frequent in Caucasian type 2 diabetic populations. However, the underlying cellular mechanisms contributing to the pathogenesis of type 2 diabetes remain uncharacterized. Chronic elevation of plasma free fatty acids observed in obese and type 2 diabetic subjects leads to cytosolic accumulation of long-chain acyl CoAs (LC-CoAs) in pancreatic β-cells. We postulated that the documented stimulatory effects of LC-CoAs on KATP channels might be enhanced in polymorphic KATP channels. Patch-clamp experiments were performed on inside-out patches containing recombinant KATP channels (Kir6.2/SUR1) to record macroscopic currents. KATP channels containing Kir6.2 (E23K/I337V) showed significantly increased activity in response to physiological palmitoyl-CoA concentrations (100–1,000 nmol/l) compared with wild-type KATP channels. At physiological intracellular ATP concentrations (mmol/l), E23K/I337V polymorphic KATP channels demonstrated significantly enhanced activity in response to palmitoyl-CoA. The observed increase in KATP channel activity may result in multiple defects in glucose homeostasis, including impaired insulin and glucagon-like peptide-1 secretion and increased glucagon release. In summary, these results suggest that the E23K/I337V polymorphism may have a diabetogenic effect via increased KATP channel activity in response to endogenous levels of LC-CoAs in tissues involved in the maintenance of glucose homeostasis.
- FFA, free fatty acid
- GLP-1, glucagon-like peptide-1
- IC50, half-maximal inhibitory concentration
- KATP, ATP-sensitive potassium
- LC-CoA, long-chain acyl CoA
Footnotes
-
- Accepted June 24, 2003.
- Received February 18, 2003.
- DIABETES














